SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 197 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 1.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $3,688,000 | -43.6% | 27,900 | -68.4% | 0.02% | -42.9% |
Q1 2018 | $6,535,000 | +343.4% | 88,200 | +267.5% | 0.03% | +154.5% |
Q3 2016 | $1,474,000 | +263.1% | 24,000 | +15.4% | 0.01% | +266.7% |
Q1 2016 | $406,000 | -25.6% | 20,800 | +22.4% | 0.00% | 0.0% |
Q3 2015 | $546,000 | +45.6% | 17,000 | -34.4% | 0.00% | 0.0% |
Q4 2014 | $375,000 | -61.8% | 25,900 | +24.5% | 0.00% | +200.0% |
Q3 2013 | $982,000 | – | 20,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |